AcquisitionOther
Quince Therapeutics, Inc. acquired Orphai Therapeutics Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Quince Therapeutics, Inc. -> Orphai Therapeutics Inc. · up to $187 million
Brings Orphai's lead program LAM-001 into Quince's pipeline
Open source record (SEC) ↗